APOB and cerebrovascular disorder: Previous research has proved the key role of LDL-C and Apo B, which was set as the primary target goal for anti-atherogenic therapy in the clinical guideline in different countries.2,39 Our research further confirmed that TG-rich remnant lipids may be independent risk factors for cardiovascular and cerebrovascular diseases after adjusted for LDL-C and HDL-C.